Stay updated on NRP 104 Likeability & Safety in Stimulant Abuse Clinical Trial
Sign up to get notified when there's something new on the NRP 104 Likeability & Safety in Stimulant Abuse Clinical Trial page.

Latest updates to the NRP 104 Likeability & Safety in Stimulant Abuse Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a dedicated Locations section featuring Maryland; the prior Maryland Locations entry was removed. Updated the revision to v3.3.3 (replacing v3.3.2) and removed the HHS Vulnerability Disclosure link.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2 on the page. This appears to be a cosmetic update that does not affect the study information or user experience.SummaryDifference0.1%

- Check49 days agoChange DetectedRemoval of the government funding and operating status notice from the page.SummaryDifference0.4%

- Check71 days agoChange DetectedThe new screenshot shows only superficial UI changes and layout adjustments, with no edits to the study's core details such as eligibility criteria, interventions, endpoints, or enrollment numbers. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check94 days agoChange Detected- Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.SummaryDifference4%

- Check101 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

Stay in the know with updates to NRP 104 Likeability & Safety in Stimulant Abuse Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NRP 104 Likeability & Safety in Stimulant Abuse Clinical Trial page.